中国医药品牌怎么样 申请店铺

我要投票 中国医药在化学药物行业中的票数:130 更新时间:2025-03-08
中国医药是哪个国家的品牌?「中国医药」是 中国医药集团有限公司 旗下著名品牌。该品牌发源于北京市,由创始人佘鲁林在1987-03-26期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中国医药品牌出海!通过在本页面挂载中国医药品牌的产品链接和联系邮箱,可以提高中国医药产品曝光!跨境电商爆单神器,目前只要100元/年哦~

中国医药怎么样

中国医药健康产业股份有限公司是在上海证券交易所挂牌的国有控股上市公司(股票简称:中国医药;证券代码:600056),其控股股东为中央骨干企业中国通用技术(集团)控股有限公司。公司秉承“关爱生命、追求卓越”的核心理念,致力于医药产业发展和人类健康事业,努力打造中国医药领域的旗舰企业。

公司已经建立起了以国际贸易为引领、以医药工业为支撑、以医药商业为纽带的科工贸一体化产业格局,产业形态涉及研发、种植加工、生产、分销、物流、进出口贸易、学术推广、技术服务等全产业链条。

在医药研发生产领域,公司拥有两家博士后科研工作站及一大批高素质研发专家,曾获国家科技进步二等奖;公司拥有国内领先的化学原料药研发生产平台,国内先进的特色化学药、现代中药研发生产平台,在抗感染类、抗病毒类药物的研发生产及甘草等药材及其制品的种植加工领域处于领先地位。

在国际贸易领域,作为医药行业进出口领域传统专业主渠道,公司始终保持着领先地位,且在政府项目业务领域具备传统实力和特色优势。天然药物贸易业务坚持全产业链专业化发展模式,有机整合天然药物种植、仓储、加工、销售等产业链环节,在行业内居于领先地位。医药化工贸易业务经营范围涵盖化学原料及制剂、生物及血液制品各品规、全领域,可为客户提供一流的医药化工贸易集成服务。医疗器械贸易业务致力于为客户提供全过程项目集成化服务,并与世界各著名医疗器械生产商建立了稳固的合作关系,在进口和分销领域处于国内领先地位。健康领域大宗商品业务涉及保健食品原料、大宗农产品、精细化工原材料等,在一些重点商品进出口贸易领域有较高知名度。

在国内医药商业领域,公司已逐步建立起以高端、特色产品为核心,具有产业价值链整合协同优势的医药商业体系。已形成以北京、广东、江西、河南、河北、湖北、新疆为重点,覆盖全国的营销网络体系,并在所在区域具有较高的知名度和品牌影响力。公司建有大型物流中心,具备完善的经营资质,可为广大合作伙伴提供全方位的增值服务。

面向未来,中国医药着力在重点产品领域建立横跨国内和国际两个市场的营销网络,聚焦现代中药、特色化学制剂和生物制药等核心产业领域,打造集研发、生产、销售、服务于一体的产业链,努力将公司发展成为一家在国内医药行业中具有重要地位、在国际市场具有较强竞争力和品牌影响力的科工贸一体化大型医药企业集团。



China Pharmaceutical and Health Industry Co., Ltd. is a state-owned holding listed company (stock abbreviation: China Pharmaceutical; securities code: 600056) listed on Shanghai Stock Exchange. Its controlling shareholder is China General Technology (Group) Holding Co., Ltd., a central backbone enterprise. Adhering to the core concept of "caring for life and pursuing excellence", the company is committed to the development of pharmaceutical industry and human health, striving to build a flagship enterprise in the field of Chinese medicine. The company has established an integrated industrial pattern of science, industry and trade with international trade as the guide, pharmaceutical industry as the support and pharmaceutical business as the link. The industrial pattern involves the whole industrial chain of R & D, planting and processing, production, distribution, logistics, import and export trade, academic promotion, technical services, etc. In the field of pharmaceutical R & D and production, the company has two postdoctoral research stations and a large number of high-quality R & D experts, who have won the second prize of national science and technology progress; the company has a leading R & D and production platform for chemical raw materials, domestic advanced characteristic chemical drugs, modern Chinese medicine research and development production platform, in the R & D and production of anti infective and anti viral drugs, licorice and other medicinal materials The planting and processing field of products is in a leading position. In the field of international trade, as the traditional professional main channel in the field of import and export of pharmaceutical industry, the company has always maintained a leading position, and has traditional strength and characteristic advantages in the field of government project business. The natural medicine trade business adheres to the whole industrial chain specialized development mode, organically integrates the natural medicine planting, storage, processing, sales and other industrial chain links, and takes the leading position in the industry. The business scope of pharmaceutical and chemical trade covers chemical raw materials and preparations, biological and blood products, and all fields. It can provide customers with first-class integrated pharmaceutical and chemical trade services. The medical device trade business is committed to providing customers with the whole process of project integration services, and has established a solid cooperative relationship with the world's famous medical device manufacturers, and is in the leading position in the field of import and distribution in China. The bulk commodity business in the health sector involves health food raw materials, bulk agricultural products, fine chemical raw materials, etc., and has a high reputation in the import and export trade of some key commodities. In the field of domestic pharmaceutical business, the company has gradually established a pharmaceutical business system with high-end, characteristic products as the core and industrial value chain integration and coordination advantages. It has formed a marketing network system focusing on Beijing, Guangdong, Jiangxi, Henan, Hebei, Hubei and Xinjiang, covering the whole country, and has a high visibility and brand influence in its region. The company has built a large-scale logistics center with perfect business qualification, which can provide all-round value-added services for the vast number of partners. Facing the future, China Pharmaceutical focuses on establishing a marketing network across the domestic and international markets in key product areas, focusing on core industries such as modern Chinese medicine, characteristic chemicals and biopharmaceuticals, creating an industrial chain integrating R & D, production, sales and service, and striving to develop the company into a company with an important position in the domestic pharmaceutical industry and in the international market A large pharmaceutical enterprise group with strong competitiveness and brand influence.

本文链接: https://brand.waitui.com/755334abf.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

美股“疯狂走势”令多家顶级对冲基金认栽,2月回报率整体惨淡

据报道,Millennium Management、城堡投资等顶级对冲基金2月回报率平平,因市场动荡扭转了几个关键交易的势头并重创热门股走势。股票市场持中性偏好的多策略基金受到的冲击最大。据悉,Jain Global回报率为-1%,Millennium下跌1.3%,城堡投资下跌1.7%。PivotalPath多策略基金指数2月上涨0.2%。(界面新闻)

2小时前

Manus官方X账号解冻

3月8日,中国AI智能体企业ManusAI官方账号已经复原。“我们回归了,提醒下,这是我们唯一官方账号,接下来我们会继续分享炫酷的用例,敬请期待。”ManusAI(ManusAI_HQ)官方账号指出。Manus首席科学家和联合创始人季逸超也第一时间公布了这一消息,并重申:“Manus从未参与任何加密货币项目、代币发行、区块链首发等。任何有相近名称的虚拟货币,其声称与我们有关的提法都是虚假的。”(21财经)

2小时前

全国政协委员蔡建春:建议加快推进多层次不动产投资信托基金市场建设

全国政协委员、上交所总经理蔡建春在提案中建议加快推进多层次不动产投资信托基金(REITs)市场建设。具体包括:一是首发与扩募并重,“双轮驱动”市场扩容。二是加快引入增量资金,活跃REITs市场。优化保险资金等各类机构投资者投资REITs风险因子,降低资本占用,推动社保基金投资REITs政策尽快落地,将REITs纳入企业年金、养老金投资范围。加快推出REITs-ETF产品和指数化产品,推动将REITs纳入公募基金投资范围和沪深港通标的。三是加快专门立法,优化产品结构。(证券时报)

2小时前

黑石集团最新房地产债务战略基金完成80亿美元募资

黑石集团当地时间3月7日宣布,其最新房地产债务战略基金BREDS V募资最终关闭,获得近80亿美元总资本承诺。据介绍,黑石BREDS管理着770亿美元资产。(界面新闻)

2小时前

私募股权公司Sycamore将以近100亿美元价格私有化连锁药店沃博联

私募股权公司Sycamore Partners与老牌连锁药店沃博联达成最终协议,以近100亿美元价格将后者私有化,包括债务在内的交易总价值为237亿美元。这笔交易预计将于今年四季度完成。沃博联的市值自2015年以来已下跌90%,截至当地时间6日为93亿美元。(界面新闻)

2小时前

本页详细列出关于上海医药的品牌信息,含品牌所属公司介绍,上海医药所处行业的品牌地位及优势。
咨询